Dynamic chest radiography a suitable, low-cost alternative to V/Q scanning for pulmonary hypertension

The use of dynamic chest radiography (DCR) was recently shown to be comparable to lung ventilation-perfusion (V/Q) scanning for detecting chronic thromboembolic pulmonary hypertension.  

Authors of a new paper published in Radiology detailed their recent analysis that did a side-by-side comparison of the two modalities and found that DCR achieved a sensitivity, specificity and accuracy that was in line with that of conventional V/Q scanning when it came to the detection of chronic thromboembolic pulmonary hypertension (CTEPH). The results of the study prompted experts involved in its completion to offer their support to the use of DCR in settings where V/Q scanning might not be readily available. 

One of the first steps in diagnosing chronic pulmonary embolism in PH is with a V/Q scan. However, the scan is not widely available outside of academic medical centers, and the use of molybdenum 99 and technetium 99m—radioisotopes that cannot be stored—during isotope shortages threatens the ability to conduct the exam. Furthermore, patients undergoing the exam are subjected to higher doses of ionizing radiation.

For these reasons, corresponding author Yuzo Yamasaki of Kyushu University and colleagues emphasized the need for an option with greater flexibility and less ionizing radiation. 

That’s where DCR comes in. DCR is a functional technique that utilizes conventional x-ray technology—a flat-panel detector, pulsed x-ray generator and a special postprocessing station. It captures sequential images during 7 to 10 seconds of breath-holding and does not require contrast media or radionuclides. It also emits a fraction of the radiation dose of typical V/Q scans. 

In a cohort of 50 patients with pulmonary hypertension—29 with CTEPH and 21 without—the researchers also found DCR to be an effective diagnostic tool. It achieved sensitivity, specificity and accuracy of 97%, 86%, and 92%. In comparison, these numbers were 100%, 86%, and 94% for V/Q scans. 

The authors acknowledged that additional studies are needed to confirm their findings in a clinical setting but suggest that their findings support the use of DCR as an alternative low-cost option in the absence of V/Q scanning technology. 

The study abstract is available here

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup